Advertisement

Gov't Approves First-Ever Med with Digital Tracking System

Gov't Approves First-Ever Med with Digital Tracking System

November 14, 2017 04:42 PM

WASHINGTON (AP) - The Food and Drug Administration has approved the first drug in the United States with a digital ingestion tracking system in an unprecedented step to ensure that patients with mental disorders take the medicine prescribed for them.

Advertisement – Content Continues Below

The drug Abilify MyCite was developed by Otsuka Pharmaceutical Co., Ltd. Abilify was first approved by the FDA in 2002 to treat schizophrenia, and the ingestible sensor, made by Proteus Digital health, was initially approved for marketing in 2012. The agency says the digitally enhanced medication "works by sending a message from the pill's sensor to a wearable patch."

Dr. Mitchell Mathis of the FDA says officials support "use of new technology in prescription drugs and is committed to working with companies to understand how the new technology might benefit patients and prescribers."


WDIO

Copyright 2017 The Associated Press. All rights reserved.

Advertisement
Advertisement
Relay Media Amp

Nolan Staying on Swanson Ticket Despite Calls to Step Aside

Former Campaign Manager Joe Radinovich, Others Weigh in on Nolan Staffer Allegations

Duluth Facility First in Minn. to Offer Kids Residential Psychiatric Treatment

Cliffs' CEO Ready for New Leadership in Minnesota

Walker Wants Federal Disaster Declaration for NW Wisconsin

Lake Superior Circle Tour Highway Reopens after Brief Closure

Advertisement